Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan
- PMID: 39264505
- DOI: 10.1007/s10875-024-01795-6
Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan
Abstract
Background: IL10RA (IL10 receptor subunit alpha) deficiency is an autosomal recessive disease that causes inflammatory bowel disease during early infancy. Its clinical course is often fatal and the only curative treatment is allogeneic hematopoietic cell transplantation (HCT). In Japan, only case reports are available, and there are no comprehensive reports of treatment outcomes.
Methods: We retrospectively analyzed patients with IL10RA deficiency in Japan.
Results: Two newly identified and five previously reported patients were included in this study. Five patients underwent HCT; one untransplanted patient survived to age 14, and one died of influenza encephalopathy before transplantation. All five HCT recipients underwent HCT at the age before 2 years. They all were conditioned with fludarabine/busulfan- or fludarabine /melphalan-based regimens. The donor source was human leukocyte antigen haploidentical donor bone marrow (BM) for two patients and unrelated umbilical cord blood (CB) for two patients. One patient experienced graft failure with unrelated CB and required a second transplant with unrelated BM. All patients who underwent HCT survived and demonstrated an improved performance status.
Conclusion: In cases of IL10RA deficiency, the need for transplantation should be promptly assessed, and early transplantation should be considered. (190/250).
Keywords: Busulfan; Fludarabine; Hematopoietic cell Transplantation; IL10RA Deficiency; Inborn Errors of Immunity; Japan; Melphalan.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity.J Clin Immunol. 2024 May 22;44(6):126. doi: 10.1007/s10875-024-01734-5. J Clin Immunol. 2024. PMID: 38773000
-
Umbilical Cord Blood Transplantation Corrects Very Early-Onset Inflammatory Bowel Disease in Chinese Patients With IL10RA-Associated Immune Deficiency.Inflamm Bowel Dis. 2018 Jun 8;24(7):1416-1427. doi: 10.1093/ibd/izy028. Inflamm Bowel Dis. 2018. PMID: 29788474
-
Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.Biol Blood Marrow Transplant. 2010 Jun;16(6):818-23. doi: 10.1016/j.bbmt.2010.01.002. Epub 2010 Jan 14. Biol Blood Marrow Transplant. 2010. PMID: 20079864
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
[Treatment of Gaucher disease with allogeneic hematopoietic stem cell transplantation: report of three cases and review of literatures].Zhonghua Er Ke Za Zhi. 2015 Nov;53(11):810-6. Zhonghua Er Ke Za Zhi. 2015. PMID: 26758318 Review. Chinese.
Cited by
-
Hematopoietic stem cell transplantation in Crohn's disease: a comprehensive review.Curr Opin Gastroenterol. 2025 Jul 1;41(4):175-181. doi: 10.1097/MOG.0000000000001096. Epub 2025 Apr 14. Curr Opin Gastroenterol. 2025. PMID: 40232992 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources